190 related articles for article (PubMed ID: 28138968)
1. Recurrence after resection with curative intent for distal cholangiocarcinoma.
Komaya K; Ebata T; Shirai K; Ohira S; Morofuji N; Akutagawa A; Yamaguchi R; Nagino M;
Br J Surg; 2017 Mar; 104(4):426-433. PubMed ID: 28138968
[TBL] [Abstract][Full Text] [Related]
2. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.
Maeta T; Ebata T; Hayashi E; Kawahara T; Mizuno S; Matsumoto N; Ohta S; Nagino M;
Br J Surg; 2017 Oct; 104(11):1549-1557. PubMed ID: 28782798
[TBL] [Abstract][Full Text] [Related]
3. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma.
Kobayashi A; Miwa S; Nakata T; Miyagawa S
Br J Surg; 2010 Jan; 97(1):56-64. PubMed ID: 19937985
[TBL] [Abstract][Full Text] [Related]
4. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
5. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent intrahepatic cholangiocarcinoma.
Sulpice L; Rayar M; Boucher E; Pracht M; Meunier B; Boudjema K
Br J Surg; 2012 Dec; 99(12):1711-7. PubMed ID: 23132419
[TBL] [Abstract][Full Text] [Related]
8. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
9. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
[TBL] [Abstract][Full Text] [Related]
10. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
12. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.
Tamandl D; Kaczirek K; Gruenberger B; Koelblinger C; Maresch J; Jakesz R; Gruenberger T
Br J Surg; 2009 Aug; 96(8):919-25. PubMed ID: 19591163
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategy for patients with middle and lower third bile duct cancer.
Todoroki T; Kawamoto T; Koike N; Fukao K; Shoda J; Takahashi H
Br J Surg; 2001 Mar; 88(3):364-70. PubMed ID: 11260100
[TBL] [Abstract][Full Text] [Related]
15. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
16. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
17. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma.
Kiriyama M; Ebata T; Aoba T; Kaneoka Y; Arai T; Shimizu Y; Nagino M;
Br J Surg; 2015 Mar; 102(4):399-406. PubMed ID: 25611179
[TBL] [Abstract][Full Text] [Related]
19. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors.
Zhou Y; Liu S; Wu L; Wan T
Asian J Surg; 2017 Apr; 40(2):129-138. PubMed ID: 26337377
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following resection of intrahepatic cholangiocarcinoma.
Tabrizian P; Jibara G; Hechtman JF; Franssen B; Labow DM; Schwartz ME; Thung SN; Sarpel U
HPB (Oxford); 2015 Apr; 17(4):344-51. PubMed ID: 25395176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
